Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$769M |
| 2 |
Meta Platforms (Facebook)
META
|
+$382M |
| 3 |
Roblox
RBLX
|
+$329M |
| 4 |
Tesla
TSLA
|
+$287M |
| 5 |
Qualcomm
QCOM
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$407M |
| 2 |
Visa
V
|
+$345M |
| 3 |
Snowflake
SNOW
|
+$344M |
| 4 |
Micron Technology
MU
|
+$278M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.91% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 12.02% |
| 4 | Consumer Discretionary | 9.99% |
| 5 | Communication Services | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CANO
3301
DELISTED
Cano Health, Inc.
CANO
| $247K | ﹤0.01% |
+195
| New | +$236K |
|
|
PVG
3302
DELISTED
PRETIUM RESOURCES INC.
PVG
| $247K | ﹤0.01% |
25,660
-130,157
| -84% | -$1.24M |
|
3303
Kopin
KOPN
$756M
| $246K | ﹤0.01% |
47,945
-1,437
| -3% | -$8.72K |
|
3304
MVB Financial
MVBF
$394M
| $246K | ﹤0.01% |
5,755
+69
| +1% | +$2.81K |
|
|
TOIIW
3305
CALL
DELISTED
The Oncology Institute Warrant
TOIIW
| $246K | ﹤0.01% |
200,000
-59,757
| -23% | -$82.3K |
|
3306
Pliant Therapeutics
PLRX
$65M
| $245K | ﹤0.01% |
14,481
-445
| -3% | -$9.44K |
|
|
HTB
3307
HomeTrust Bancshares
HTB
$863M
| $245K | ﹤0.01% |
8,746
-278
| -3% | -$7.64K |
|
3308
Bolt Biotherapeutics
BOLT
$7.44M
| $244K | ﹤0.01% |
968
+624
| +181% | +$176K |
|
3309
Taysha Gene Therapies
TSHA
$1.82B
| $244K | ﹤0.01% |
13,108
-414
| -3% | -$7.87K |
|
|
KDNY
3310
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $243K | ﹤0.01% |
19,044
+373
| +2% | +$4.91K |
|
|
XONE
3311
DELISTED
The ExOne Company
XONE
| $243K | ﹤0.01% |
10,389
-4,394
| -30% | -$92.2K |
|
3312
Kirby Corp
KEX
$7.11B
| $242K | ﹤0.01% |
5,042
-97,425
| -95% | -$5.4M |
|
|
ALIM
3313
DELISTED
Alimera Sciences
ALIM
| $242K | ﹤0.01% |
57,368
| – | – |
|
3314
Applied Optoelectronics
AAOI
$9.97B
| $241K | ﹤0.01% |
33,596
+22,388
| +200% | +$165K |
|
3315
Miller Industries
MLR
$620M
| $241K | ﹤0.01% |
7,089
+473
| +7% | +$17.5K |
|
3316
Oppenheimer Holdings
OPY
$1.22B
| $241K | ﹤0.01% |
5,317
-6,993
| -57% | -$314K |
|
|
ICVX
3317
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $241K | ﹤0.01% |
+8,147
| New | +$276K |
|
3318
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.96B
| $239K | ﹤0.01% |
5,495
-75
| -1% | -$3.36K |
|
3319
Titan International
TWI
$465M
| $238K | ﹤0.01% |
33,232
-64,840
| -66% | -$512K |
|
|
AFI
3320
DELISTED
Armstrong Flooring, Inc.
AFI
| $238K | ﹤0.01% |
75,960
| – | – |
|
3321
Farmers National Banc Corp
FMNB
$936M
| $237K | ﹤0.01% |
15,097
-486
| -3% | -$7.47K |
|
|
NOTV
3322
DELISTED
Inotiv
NOTV
| $236K | ﹤0.01% |
8,050
-244
| -3% | -$7.1K |
|
3323
Latham Group
SWIM
$848M
| $236K | ﹤0.01% |
14,376
-433
| -3% | -$10.1K |
|
|
OSTRU
3324
DELISTED
Oyster Enterprises Acquisition Corp. Unit
OSTRU
| $236K | ﹤0.01% |
23,556
+13,000
| +123% | +$130K |
|
3325
SoundThinking
SSTI
$101M
| $234K | ﹤0.01% |
6,422
-186
| -3% | -$7.81K |
|
Similar funds
Deutsche Bank's Q3 2021 Portfolio in Review
As of Q3 2021, Deutsche Bank held 4,855 positions worth $211B, up 2.4% from $206B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Deutsche Bank's Q3 2021 filing shows 198 new, 1,525 increased, 2,234 reduced and 397 closed positions. Its largest new stake was AfterNext HealthTech Acquisition Corp Units: 1,163,081 shares worth $11.6M. The largest sale was Alexion Pharmaceuticals, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q3 2021 buy was AfterNext HealthTech Acquisition Corp Units: 1,163,081 shares worth $11.6M.
- Deutsche Bank added most to Amazon in Q3 2021, an estimated $769M increase.
- Deutsche Bank's biggest Q3 2021 reduction was Visa, cutting an estimated $345M.
- Deutsche Bank fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $407M.
- Deutsche Bank's ten largest holdings make up 20% of its $211B portfolio in Q3 2021.
- Deutsche Bank opened 198 new positions and closed 397 in Q3 2021.
- Deutsche Bank's portfolio value rose 2.4% quarter-over-quarter to $211B.
Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.